In an interesting piece first reported by the National Business Review on 2 November, current English Premier League champions, Chelsea Football Club, have given notice to oppose Apotex's (a Canadian pharmaceutical company) application to register the trade mark 'Chelsea' in New Zealand for pharmaceutical preparations, namely oral contraceptives.
In its notice of opposition released to the NBR, Chelsea Football Club claims Apotex's registration of the mark in relation to its oral contraceptive product, would be likely to 'mislead, deceive or confuse people into thinking [those] goods are connected to the club'.
AJ Park partner John Hackett comments on the case in an interview with NBR Radio.
